Swedish registry study: HPV vaccination almost eliminates cervical cancer when given before 17
Among 1.7 million Swedish girls and women, quadrivalent HPV vaccination cut invasive cervical cancer by 88% when given before age 17 and by about half when given at 17-30.
A nationwide cohort of 1,672,983 girls and women aged 10-30 was followed from 2006 to 2017 through Swedish registries, linking HPV vaccination status to invasive cervical cancer diagnoses. Analyses adjusted for age, calendar year, county and parental characteristics.
Cumulative incidence of cervical cancer by age 30 was 47 per 100,000 in vaccinated women and 94 per 100,000 in unvaccinated women. The adjusted incidence rate ratio was 0.12 for women vaccinated before 17 and 0.47 for those vaccinated at 17-30.
This was the first population-level demonstration that HPV vaccination prevents invasive cancer, not just precancerous lesions.
- Adjusted incidence rate ratio for cervical cancer 0.37 (95% CI 0.21-0.57) overall in vaccinated vs unvaccinated
- Vaccinated before age 17: IRR 0.12 (95% CI 0.00-0.34), an 88% reduction
- Vaccinated at 17-30: IRR 0.47 (95% CI 0.27-0.75)
- Cumulative incidence by age 30: 47 vs 94 per 100,000
Vaccinating girls before they are exposed to HPV prevents most cervical cancers. Catch-up vaccination in young adults still helps, but less. Combined with HPV screening, elimination of cervical cancer as a public health problem is a realistic goal.
- Observational; residual confounding by health-seeking behaviour is possible despite adjustment
- Follow-up ends at age 30, before most cervical cancers occur
- Sweden used the quadrivalent vaccine; effects for bivalent and nonavalent vaccines are inferred
- Does not address single-dose schedules or vaccination of boys
Pages like this
not linked directly; found by shared links- IdeaOffer HPV vaccination to women when they come for cervical screening or treatment
Shares England's HPV programme: cervical cancer down 87% in the first cohort vaccinated at 12-13, HPV & HBV vaccination, Prevention we already have is not deployed, Cervical cancer.
- IdeaCatch-up HPV vaccination for men to prevent throat cancer
Shares England's HPV programme: cervical cancer down 87% in the first cohort vaccinated at 12-13, HPV & HBV vaccination, Prevention we already have is not deployed, Head and neck squamous cell carcinoma.
- TrialKEN SHE (single-dose HPV vaccine)
Shares Single-dose HPV vaccination plus HPV self-sampling to reach WHO elimination in low-income countries, HPV & HBV vaccination, Prevention we already have is not deployed, Cervical cancer.
- TechnologyThermal ablation and cryotherapy for cervical precancer
Shares Single-dose HPV vaccination plus HPV self-sampling to reach WHO elimination in low-income countries, HPV DNA testing and self-sampling, Prevention we already have is not deployed, Most of the world has almost no cancer care.
- IdeaEliminate infection-caused cancers: HPV, hepatitis B and C, H. pylori and EBV
Shares HPV & HBV vaccination, Prevention we already have is not deployed, Most of the world has almost no cancer care, Cervical cancer.
- Key paperSelf-collected HPV samples are as accurate as clinician samples and reach women who never attend screening
Shares HPV DNA testing and self-sampling, HPV & HBV vaccination, Prevention we already have is not deployed, Most of the world has almost no cancer care.
- ProductNonavalent HPV vaccine
Shares Single-dose HPV vaccination plus HPV self-sampling to reach WHO elimination in low-income countries, HPV & HBV vaccination, Prevention we already have is not deployed, Most of the world has almost no cancer care.
- IdeaHPV self-testing with same-day treatment as the national cervical programme
Shares HPV & HBV vaccination, Prevention we already have is not deployed, Most of the world has almost no cancer care, Cervical cancer.